Of Note is a tight and pure collection of thoughts on healthcare and archives what I'm into and what I'm up to.

This is a weekly newsletter where I summarise industry news as well as relevant publications from the Cell and Gene Therapy space. Here we will cover, clinical trial data, manufacturing and translational research,

5 min weekly updates on Cell and Gene therapies (CRISPR, Base editing, AAV, Lentivirus, retrovirus, CAR-Ts, TCR-T, LNP, etc.) #pharma #biotech #c&g #life science #innovation #science

Facts, data and analytics about biomedical matters

Daily Biotech Public & Private Market Updates, Company Building, Financing, Exit Strategies, and Emerging Science Trends

Healthcare lies at the confluence of science, clinical practice, and regulation. I analyze trends, data, and diseases with eye toward biotech and a touch of humor

Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.